At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
UCII, glucosamine and curcumin +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of UC-II, Glucosamine and Curcumin Supplementation on Knee Pain and Inflammation: A Randomized, Single-blind, Placebo-controlled Parallel-group Trial
In Brief
A clinical study evaluating UCII, glucosamine and curcumin and Placebo for Inflammation and Knee Pain Chronic. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This research evaluated the effects of UCII, glucosamine and curcumin supplementation on knee pain and inflammation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation, Knee Pain Chronic
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartAug 2024
First PostedSep 2024
Primary CompletionNov 2024
Study CompletionDec 2024
TodayJul 2026
First PostedSep 3, 2024
Enrollment StartAug 20, 2024
Primary CompletionNov 14, 2024
Study CompletionDec 3, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.8 years ago
Interventions
UCII, glucosamine and curcumindietary
compound capsules twice daily.
Placebodietary
Placebo capsules twice daily.